Haukka, Jani K. http://orcid.org/0000-0001-5663-0923
Sandholm, Niina http://orcid.org/0000-0003-4322-6942
Forsblom, Carol http://orcid.org/0000-0002-3354-7454
Cobb, Jeffrey E.
Groop, Per-Henrik http://orcid.org/0000-0003-4055-6954
Ferrannini, Ele http://orcid.org/0000-0002-1384-1584
Article History
Received: 1 May 2018
Accepted: 13 August 2018
First Online: 14 September 2018
Competing Interests
: P.-H.G. has served on advisory boards for AbbVie, AstraZeneca, Boehringer Ingelheim, Cebix, Eli Lilly, Janssen, Medscape, MSD, Novartis, Novo Nordisk, Sanofi, and has received lecture honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Elo Water, Genzyme, Medscape, MSD, Novartis, Novo Nordisk and Sanofi. P.-H. G. has also received investigator-initiated grants from Eli Lilly and Roche. E.F. has served on advisory boards for MSD, Boehringer Ingelheim, Sanofi, and has received lecture honoraria from AstraZeneca, Boehringer Ingelheim, Sanofi, Novo Nordisk and Mitsubishi-Tanabe. E.F. has received investigator-initiated funding from Boehringer Ingelheim and Eli Lilly. J.E.C. is a former employee of Metabolon, Inc., Durham, NC.